How big is the microalgae industry?

The global microalgae market size is expected to increase USD 25.72 billion by 2033 from USD 11.86 billion in 2023. Read More

What will be the CAGR of global microalgae industry?

The global microalgae market will register growth rate of 8.05% between 2024 and 2033. Read More

Who are the prominent players operating in the microalgae market?

The major players operating in the microalgae market are Bristol Myers Squibb Company, Amgen Inc., Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Incorporated, Gilead Sciences Inc., Moderna Inc. BioNTech SE, WuXi STA, Aragen Bioscience Inc., MedChemExpress LLC, Promega Corporation, Sai Life Sciences Limited, BioAscent Discovery Limited, SRI International, Peak Protein Ltd., Sygnature Discovery Limited, Aptuit LLC, ChemPartener Corporation, BioDuro LLC, Concept Life Sciences Group Limited, Selcia Limited, Pharmaron Beijing Co. Ltd, Viva Biotech Holdings, and Others. Read More

Which are the driving factors of the microalgae market?

The driving factors of the microalgae market are the Rising vegetarians and preference for microalgae-sourced products. Read More

Which region will lead the global microalgae market?

North America region will lead the global microalgae market during the forecast period 2024 to 2033. Read More

Microalgae Market Size, Share, and Trends 2024 to 2033

Microalgae Market (By Species: Spirulina, Chlorella, Dunaliella, Haematococcus, Crypthecodinium, Schizochytrium, Euglena, Nannochloropsis, Phaeydactelum, Others; By Source: Marine Water, Fresh Water; By End-use Application: Food and Beverages Sector, Health and Medical Sector, Animal Feed Sector, Pet Food Sector, Cosmetics and Personal Care Sector, Fertilizers Sector) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Last Updated : July 2024
Report Code : 4637
Category : Food and Beverages

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Microalgae Market

5.1. COVID-19 Landscape: Microalgae Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Microalgae Market, By Species

8.1. Microalgae Market Revenue and Volume, by Species, 2024-2033

8.1.1 Spirulina

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Chlorella

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Dunaliella

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Haematococcus

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Crypthecodinium

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

8.1.6. Schizochytrium

8.1.6.1. Market Revenue and Volume Forecast (2021-2033)

8.1.7. Euglena

8.1.7.1. Market Revenue and Volume Forecast (2021-2033)

8.1.8. Phaeydactelum

8.1.8.1. Market Revenue and Volume Forecast (2021-2033)

8.1.9. Others

8.1.9.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Microalgae Market, By Source

9.1. Microalgae Market Revenue and Volume, by Source, 2024-2033

9.1.1. Marine Water

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Fresh Water

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Microalgae Market, By End-use Application

10.1. Microalgae Market Revenue and Volume, by End-use Application, 2024-2033

10.1.1. Food and Beverages Sector

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Health and Medical Sector

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Animal Feed Sector

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Pet Food Sector

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

10.1.5. Cosmetics and Personal Care Sector

10.1.5.1. Market Revenue and Volume Forecast (2021-2033)

10.1.6. Fertilizers Sector

10.1.6.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Microalgae Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.1.4.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.1.4.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.1.5.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.1.5.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.2.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.2.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.2.4.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.2.4.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.2.5.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.2.5.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.2.6.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.2.6.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.2.7.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.2.7.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.3.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.3.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.3.4.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.3.4.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.3.5.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.3.5.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.3.6.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.3.6.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.3.7.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.3.7.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.4.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.4.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.4.4.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.4.4.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.4.5.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.4.5.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.4.6.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.4.6.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.4.7.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.4.7.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.5.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.5.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.5.4.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.5.4.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Species (2021-2033)

11.5.5.2. Market Revenue and Volume Forecast, by Source (2021-2033)

11.5.5.3. Market Revenue and Volume Forecast, by End-use Application (2021-2033)

Chapter 12. Company Profiles

12.1. Bristol Myers Squibb Company

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Amgen Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Regeneron Pharmaceuticals Inc

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Vertex Pharmaceuticals Incorporated

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Gilead Sciences Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Moderna Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. BioNTech SE

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. WuXi STA

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Aragen Bioscience Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. MedChemExpress LLC

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

We use cookies to improve your experience

Microalgae Market Size to Hit Around USD 25.72 Bn By 2033

List of Contents